REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Ge Pharmaceuticals OOD (Bulgaria)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Ge Pharmaceuticals OOD Profile Updated: September 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Ge Pharmaceuticals OOD is based in Bulgaria, with the head office in Botevgrad. It operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on July 11, 2005. It currently has a total number of 164 (2023) employees. From the latest financial highlights, Ge Pharmaceuticals OOD reported a net sales revenue increase of 23.74% in 2022. Its’ total assets recorded a growth of 4.52%. In, 2022, the company’s net profit margin increased by 1.67%.

Headquarters
zh.k. Promishlena Zona M. Chekanitsa Yug
Botevgrad; Sofia; Postal Code: 2140

Contact Details: Purchase the Ge Pharmaceuticals OOD report to view the information.

Website: http://www.ge-ph.com

Basic Information
Total Employees:
Purchase the Ge Pharmaceuticals OOD report to view the information.
Outstanding Shares:
Purchase the Ge Pharmaceuticals OOD report to view the information.
Registered Capital:
Purchase the Ge Pharmaceuticals OOD report to view the information.
Financial Auditors:
Purchase the Ge Pharmaceuticals OOD report to view the information.
Incorporation Date:
July 11, 2005
Key Executives
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Procurator
Purchase this report to view the information.
Procurator
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Ge Pharmaceuticals OOD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
23.74%▲
Total operating revenue
10.3%▲
Net Profit (Loss) for the Period
41.57%▲
Total assets
4.52%▲
Total equity
4.91%▲
Net Profit Margin
1.67%▲
Return on Equity (ROE)
2.72%▲
Quick Ratio
0.35%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo